Results 21 to 30 of about 5,253,337 (215)
Background Aiming to the containment of the coronavirus disease 2019 (COVID-19) pandemic, governments worldwide have implemented a series of non-pharmaceutical interventions.
Theoklis Zaoutis +10 more
doaj +1 more source
Meningococcal disease occurs as both endemic and epidemic disease in most parts of the world with significant morbidity and mortality. Among the different serogroups of Neisseria meningitidis, serogroups A, B, C account for 90% of the disease. In the last few years there has been a change in the epidemiology of the disease with an increase in the ...
Ziad A, Memish, Abdulrahman A, Alrajhi
openaire +3 more sources
Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. [PDF]
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad.
Greenwood, Brian M +35 more
core +1 more source
Sibling familial risk ratio of meningococcal disease in UK Caucasians. [PDF]
To quantify the host genetic component of meningococcal disease (MD) susceptibility, the sibling risk ratio (lambdaS) was calculated as the ratio of observed MD cases among 845 siblings of 443 UK Caucasian cases to that expected, calculated from age ...
Haralambous, E +5 more
core +1 more source
Clusters of meningococcal disease in educational establishments in the United Kingdom: April 2001 to March 2002. [PDF]
Clusters of meningococcal disease in school and pre-school settings generate high levels of public anxiety. Thus, cluster detection and reporting is crucial to trigger prompt public health measures, and detailed study is essential to shape future public ...
Davison, K +4 more
core +4 more sources
Molecular epidemiology of meningococcal disease in Northern Ghana [PDF]
Meningococcal disease remains a major public health concern, especially in the African Meningitis Belt where large meningitis epidemics with attack rates of up to 500/100,000 recur every 8-12 years.
Gagneux, Sébastien
core +1 more source
Meningococcal and pneumococcal meningitis in Northern Ghana [PDF]
Despite improvements in technology, treatments and understanding of how bacterial meningitis develops, the disease remains a potentially life-threatening emergency capable of causing significant morbidity and mortality. N. meningitidis, S.
Forgor, Abdulai Adams
core +1 more source
Meningococcal Disease and Travel [PDF]
Invasive meningococcal disease, in both endemic and epidemic forms, is the cause of significant morbidity and mortality worldwide. Despite all advances in therapy, the fatality rate of meningococcal meningitis remains unacceptably high, between 5% and 10%, and a similar proportion suffers long-term neurological sequalae.
openaire +2 more sources
Social Behavior and Meningococcal Carriage in British Teenagers
Understanding predisposing factors for meningococcal carriage may identify targets for public health interventions. Before mass vaccination with meningococcal group C conjugate vaccine began in autumn 1999, we took pharyngeal swabs from ?14,000 UK ...
MacLennan, J. +43 more
core +2 more sources
Meningococcal vaccines in China
Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines.
Yinghua Xu +5 more
doaj +1 more source

